Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.
COVID-19 has hit some countries far harder than ... relative to the size of the outbreak in each country. So in these charts we use a rolling 7-day average of the new infections countries report ...
The COVAIL trial reveals that neutralizing antibody titers correlate with COVID-19 risk reduction after mRNA boosters. Learn how this impacts vaccine strategies against emerging variants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback